The Alternative Investment Fund Managers Directive (AIFMD) came into force in 2011. Broad in scope, it covers the marketing, management and administration of alternative investment funds in Europe.

Transparency is central to AIFMD. Many of the biggest challenges faced by firms within its scope relate to the rigorous fund valuation and reporting requirements it has brought into the market.

Firms are increasingly required to use certain accounting standards, such as IFRS, to determine fair value measurements for assets and liabilities and to comply with enhanced disclosure requirements. 

Thomson Reuters can help. We provide ValPoint: a comprehensive, cost-efficient solution that helps you meet AIFMD requirements. 

ValPoint for AIFMD:

ValPoint combines the depth and breadth of Thomson Reuters pricing and valuation expertise, including evaluated pricing on over 2.6 million instruments daily, plus the specialized expertise of Value & Risk: individual pricing policies, validation procedures and the pricing of highly complex instruments. Together, we deliver full, independent and transparent pricing and valuations solutions across your entire fund.

Key features:

  • Structured as a one-stop service that provides pricing coverage of portfolios of any size, including liquid and illiquid securities within all asset classes and complexity levels
  • A transparent analytical, reporting and documentation solution
  • Business support and audit reports for conflicting cases (Asset Manager vs. Custodian)
  • Tradeweb data available to subscribers
  • Rigorous quality control - ISAE 3402 (Type II) Certificate
  • Market expertise, telephone access, customized training course, and investment analysis available on request
  • Cost efficiency and simplicity; access to the ValPoint service all under one contract

For more information, or to speak to a sales representative, please click here.


NEW! In order to better understand what regulatory data you need to comply with AIFMD, how you can lower your regulatory data spend and comply with multiple regulations like AIFMD at the same time, we have created a free regulatory data solutions diagnosis tool which aims to do just that!


Visit and obtain your bespoke market research today to learn how you can reduce costs and remain compliant at the same time.